Singapore markets close in 2 hours 44 minutes

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.81+0.34 (+2.73%)
At close: 04:00PM EDT
12.81 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-1.44-1.37-5.79-5.27
Low estimate-1.73-1.78-6.3-6.14
High estimate-1.18-0.91-5.14-4.68
Year ago EPS-1.86-1.33-6.38-5.79
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7767
Avg. Estimate17.46M17.57M69.1M74.03M
Low estimate15.12M16M67.59M63M
High estimate20M21M71.5M111.94M
Year ago salesN/A18.93M79.2M69.1M
Sales growth (year/est)N/A-7.20%-12.80%7.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.34-2.15-1.19-1.33
Actual EPS-1.86-1.33-1.58-1.47
Difference0.480.82-0.39-0.14
Surprise %20.50%38.10%-32.80%-10.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.44-1.37-5.79-5.27
7 days ago-1.44-1.37-5.79-5.27
30 days ago-1.23-1.03-5.09-4.67
60 days ago-1.23-1.03-5.09-4.67
90 days ago-1.22-0.98-5.13-4.82
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1112
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesENTAIndustrySector(s)S&P 500
Current qtr.22.60%N/AN/AN/A
Next qtr.-3.00%N/AN/AN/A
Current year9.20%N/AN/AN/A
Next year9.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)-10.60%N/AN/AN/A